ArticleHemaSphere2023

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study.

William Townsend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.